1. Antibody-drug Conjugate/ADC Related
  2. ADC Cytotoxin
  3. Akt/ROCK-IN-1

Akt/ROCK-IN-1 (B12) 是 AktROCK 的双重抑制剂,IC50 分别为 0.023 nM 和 1.47 nM。 AKT/Rock-In-1 具有神经母细胞瘤的抗肿瘤活性。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

Akt/ROCK-IN-1 Chemical Structure

Akt/ROCK-IN-1 Chemical Structure

CAS No. : 2983889-44-5

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

Akt/ROCK-IN-1 (B12) is a dual inhibitor for Akt and ROCK, with the IC50s of 0.023 nM and 1.47 nM, respectively. Akt/ROCK-IN-1 has antitumor activity for neuroblastoma[1].

体外研究
(In Vitro)

Akt/ROCK-IN-1 (0.5 μM;0-72 h ) 在 Neuro2a 细胞中显示出强大的抗增殖效应和出色的分化诱导活动[1]
Akt/ROCK-IN-1 (800 nM ) 导致 Neuro2a 细胞显著增加在 G0/G1 期的细胞比例[1]
Akt/ROCK-IN-1 (0.5, 2 μM) 导致 mTOR, GSK-3β 和 PRAS40 的磷酸化水平显著下降,而 Akt 的磷酸化水平则表现出反馈性增加[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

体内研究
(In Vivo)

Akt/ROCK-IN-1 (20, 40 mg/kg; i.p.; 每天注射持续14天) 可抑制植入 Neuro2a 细胞的小鼠的肿瘤生长[1]
Akt/ROCK-IN-1 (10 mg/kg; i.p., p.o.单剂量) 与口服给药相比,腹腔注射在大鼠体内产生更好的药代动力学参数[1]

Pharmacokinetic Analysis in ICR mice Model[1]

药代动力学分析[1]

Route Dose (mg/kg) Tmax (h) T1/2 (h) Cmax (ng/mL) Cl (mL·h/kg) AUC0-t (ng·h/mL) AUC0-∞ (ng·h/mL) MRT (h) Vss/Vd (L/kg)
p.o. 10 2.0 4.3 96.3 15374.1 481.8 650.4 6.2 96
i.p. 10 0.3 2.2 561.3 5934.9 1548.9 1685.0 3.2 19.0

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: mice were implanted with Neuro2a cells[1]
Dosage: 20 mg/kg and 40 mg/kg; everyday for 14d
Administration: i.p
Result: Inhibited tumor growth compared to the vehicle control.Mice maintained stable body weights throughout the treatment, indicating a favorable safety profile. Post-treatment analysis showed significant differentiation in tumor cells, demonstrated by increased expression of differentiation markers.
Animal Model: SD rats or ICR mice[1]
Dosage: 10 mg/kg; Single Dose
Administration: i.p.; p.o.
Result: Showed low oral bioavailability and plasma stability, particularly in rat liver microsomes with only 18.0% remaining after 1 hour.
Intraperitoneal administration resulted in better pharmacokinetic parameters compared to oral administration, suggesting that this route could be more suitable for achieving therapeutic plasma concentrations.
分子量

509.37

Formula

C21H19BrF2N4O2S

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
Akt/ROCK-IN-1
目录号:
HY-156796
需求量: